Alto Neuroscience Inc.

ANRONYSE • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
36.52 USD
↘ 0.02 (0.04%)🟢PRE MARKET (AS OF 04:36 AM EDT)
🟢Market: OPEN

Alto Neuroscience Inc. (ANRO) trades at $36.52 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place ANRO at a fair price relative to peers.

Technical & fundamental data as of Aug 26, 2026.

Open?$35.80
High?$38.19
Low?$34.86
Prev. Close?$36.53
Volume?239.8K
Avg. Volume?461.2K
VWAP?$36.11
Rel. Volume?0.52x
Bid / Ask
Bid?$36.00 × 100
Ask?$40.00 × 100
Spread?$4.00
Midpoint?$38.00
Valuation & Ratios
Market Cap?1.4B
Shares Out?39.2M
Float?25.3M
Float %?72.0%
P/E Ratio?N/A
P/B Ratio?6.54
EPS?-$2.15
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Themes
Biotech - Drug Development›Neuroscience & CNSHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
68
Market Cap
1.4B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.altoneuroscience.com
Listed
2024-02-02
Address
650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW, CA 94041
Phone: 773-255-5012
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
65
Short Sent.?
29
Piotroski F-Score?0/9Weak
Altman Z-Score?23.24Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?14.07%High
Short Interest?3.6M
Days to Cover?7.5
Free Float25.3M
Avg Daily Volume476.0K
Settlement Date2026-08-14
Financial Health
Current Ratio?14.85Strong
Quick Ratio?14.85Strong
Cash Ratio?14.64Strong
Debt/Equity?0.09Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
28
6.54FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-13.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-38.4%WEAK▾
ROA?
S&P
3
-33.2%WEAK▾
Cash Flow & Enterprise
FCF?$-68841000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day
MarketsMoversWatchlist